| 1 (32) | Samsung Corp * | MUL |  |
| 2 (85) | AstraZeneca * | MUL | |
| 3 (87) | Novartis Institutes for Biomedical Research, United States | USA | |
| 4 (88) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 5 (91) | F Hoffmann-La Roche * | MUL | |
| 6 (111) | Hoffmann-La Roche Ltd, United States | USA | |
| 7 (113) | AbbVie * | MUL | |
| 8 (114) | AbbVie Inc, United States | USA | |
| 9 (131) | Genentech Inc | USA | |
| 10 (135) | Bristol-Myers Squibb Company, United States | USA | |
| 11 (136) | Merck * | MUL | |
| 12 (146) | Bristol-Myers Squibb Company * | MUL | |
| 13 (151) | AstraZeneca, United Kingdom | GBR | |
| 14 (164) | Merck & Co Inc, United States | USA | |
| 15 (177) | Daiichi Sankyo Co., Ltd. Japan | JPN | |
| 16 (178) | Daiichi Sankyo Co., Ltd. * | MUL | |
| 17 (182) | Amgen * | MUL | |
| 18 (190) | Bayer AG, Germany | DEU | |
| 19 (191) | Novartis * | MUL | |
| 20 (200) | Johnson & Johnson * | MUL | |
| 21 (206) | GlaxoSmithKline, United States | USA | |
| 22 (214) | Merck KGaA, Germany | DEU | |
| 23 (217) | Janssen | MUL | |
| 24 (222) | AstraZeneca, United States | USA | |
| 25 (225) | Eisai Co Ltd, Japan | JPN | |
| 26 (232) | Foundation Medicine Inc | USA | |
| 27 (233) | Eli Lilly and Company, United States | USA | |
| 28 (235) | Amgen, USA | USA | |
| 29 (238) | Boehringer Ingelheim * | MUL | |
| 30 (241) | Gilead Sciences Inc, United States | USA | |
| 31 (248) | Gilead Sciences * | MUL | |
| 32 (249) | Janssen Biotech Inc | USA | |
| 33 (256) | Eli Lilly * | MUL | |
| 34 (263) | Bayer * | MUL | |
| 35 (270) | Pfizer Inc, Spain Granada | ESP | |
| 36 (271) | Regeneron Pharmaceuticals Inc | USA | |
| 37 (294) | GlaxoSmithKline * | MUL | |
| 38 (298) | Pfizer * | MUL | |
| 39 (331) | Pfizer Inc, United States | USA | |
| 40 (359) | Koninklijke Philips NV * | MUL | |
| 41 (363) | Sanofi, France | FRA | |
| 42 (404) | Sanofi * | MUL | |
| 43 (407) | Boehringer Ingelheim, USA | USA | |
| 44 (432) | Takeda Pharmaceuticals International Inc * | MUL | |
| 45 (433) | Bosch, Germany | DEU | |
| 46 (440) | Boehringer Ingelheim GmbH Germany | DEU | |
| 47 (460) | Robert Bosch * | MUL | |
| 48 (522) | Sanofi, United States | USA | |
| 49 (528) | Janssen Research & Development, LLC | BEL | |
| 50 (548) | Translational Research Institute | AUS | |
| 51 (551) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 52 (568) | Novartis, Switzerland | CHE | |
| 53 (593) | General Electric Company * | MUL | |
| 54 (619) | Siemens * | MUL | |
| 55 (689) | Novo Nordisk * | MUL | |
| 56 (699) | Ormat Technologies Inc * | MUL | |
| 56 (699) | Ormat Technologies, United States | USA | |
| 58 (724) | Novo Nordisk A/S | DNK | |
| 59 (795) | Novartis Pharmaceuticals, United States | USA | |
| 60 (911) | Takeda Pharmaceuticals International Inc, USA | USA | |
| 61 (922) | GlaxoSmithKline, United Kingdom | GBR | |
| 62 (936) | ARUP Laboratories | USA | |
| 63 (946) | Bayer Corp, USA | USA | |
| 64 (1128) | GE Healthcare | MUL | |
| 65 (1169) | Siemens AG, Germany | DEU | |
| 66 (1488) | Frontiers Media SA | CHE | |
| 67 (1605) | RTI Health Solutions | USA | |
| 68 (1672) | Siemens AG, China | CHN | |
| 69 (1812) | Nippon Telegraph and Telephone Corp, Japan | JPN | |
| 70 (1833) | Nippon Telegraph and Telephone Corporation * | MUL | |
| 71 (1845) | Manipal Global Education Group * | MUL | |
| 72 (1957) | GE Healthcare, China | CHN | |
| 73 (2106) | Siemens Healthineers, Germany | DEU | |
| 74 (2232) | RTI Health Solutions * | MUL | |
| 75 (2248) | RTI Health Solutions, United States | USA | |
| 76 (2276) | Siemens Healthineers, China | CHN | |
|
